Left to right: T.J. Willi, Cristobol Zomosa, Former Raybow USA President Pete Newsome, Tim McElroy, David Perrey, Andy Stutesman, and Raybow USA President and General Manager Matt Lauer. Not pictured: Jonathan Edwards and Melissa Stutesman.

Raybow USA in Brevard, NC, recently recognized nine individuals for completing at least five years of employment with the company. Parent company JiuZhou Pharmaceutical presented a silver commemorative coin to each individual in honor of their service.

Brevard staff members gathered to honor Jonathan Edwards, Raybow USA President and General Manager Matt Lauer, Tim McElroy, Former Raybow USA President Pete Newsome, David Perrey, Andy Stutesman, Melissa Stutesman, T.J. Willi, and Cristobol Zomosa.

JiuZhou Pharmaceutical President David Mei said, “Your years of dedication have been the driving force behind our company’s steady progress. We are truly thankful for your unwavering efforts.”

Raybow USA President and General Manager Matt Lauer commented, “Our team in Brevard, North Carolina, offers exceptional knowledge and experience to customers seeking help with moving their projects from the molecular stage to their specific markets. Our long-term staff members build important connections with our clients, which helps us meet their project goals.”

About Raybow USA

Founded in 1998 as PharmAgra Labs by Peter Newsome and Roger Frisbee, the Brevard, North Carolina, company became Raybow USA, a part of Jiuzhou Pharmaceutical in 2019. The facility is dedicated to cutting-edge Research & Development and Analytical services, offering preparation of clinical trial material, method validation, and small-scale specialty manufacturing for multiple markets. The FDA-inspected site boasts a cGMP laboratory and kilo lab.

About Jiuzhou Pharma

Zhejiang Jiuzhou Pharmaceutical Co., LTD. (stock code: 603456.SH), founded in 1998 and headquartered in Taizhou, Zhejiang, is a leading CDMO and generic drug manufacturer in China. The company has production and R&D bases in China, Germany, Japan, and the United States.

Jiu Jiuzhou Pharma provides full-lifecycle contract development and manufacturing services to pharmaceutical companies worldwide. The one-stop CDMO service spans from preclinical research, process R&D for APIs, DPs, peptides, and drug conjugates, through all clinical phases to commercial production.

###